“AI is powerful, but in life sciences, it’s an augmentation, not a shortcut.” This episode of Life Sciences – In Focus features Simon Hodgkins, Chief Marketing Officer at Vistatec AI, as we explore one of the industry’s most debated topics: artificial intelligence.
Host Karen Tkaczyk takes on both interviewer and contributor roles. This creates a dynamic conversation, rich with insights, that explores the promise of AI and its practical realities in regulated environments.
AI in Life Sciences and Where Progress Meets Pragmatism
AI is everywhere, but Simon highlights that in life sciences, the reality is more nuanced.
“Yes, AI is making phenomenal progress,” he explains. “But there are regulatory challenges, data privacy concerns, and real-world complexities that can’t be ignored.”
Unlike less regulated industries, life sciences operate under strict compliance frameworks where patient safety is paramount. This creates tension: innovation must move forward, but never at the expense of accuracy, validation, or trust.
Augmentation, Not Replacement
A central theme throughout the episode is that AI is not here to replace human expertise, but to enhance it.
From radiology to drug discovery, AI is already proving its value in:
- Pattern recognition
- Data analysis at scale
- Workflow optimization
Yet, as Simon emphasizes, “It still needs a human to make the final call.”
This “human-in-the-loop” model isn’t just best practice, it’s increasingly a regulatory requirement, particularly under evolving frameworks like the EU AI Act.
The Localization Challenge and Where AI Falls Short
Karen brings a critical perspective from the localization side of the industry. She highlights one of the most misunderstood AI use cases: translation.
AI can generate multilingual content quickly. However, it often fails where it matters most.
- Cultural nuance
- Regulatory compliance
- Contextual accuracy
In clinical trials, for example, patient-facing materials must be:
- Culturally adapted
- Linguistically precise
- Audit-ready with certified validation
Traditional workflows, enhanced by AI but still reliant on human expertise, remain essential here.
As Karen explains, “We’re not talking about one human in the loop—we’re talking about two. Four eyes are required for compliance.”
Data Privacy and the Cost of AI
Another critical dimension is data security. In a world governed by GDPR, HIPAA, and emerging AI regulations, the use of AI tools must be carefully controlled.
Closed systems, proprietary models, and secure environments are no longer optional. They’re now foundational.
And then there’s cost.
“AI isn’t free,” Karen notes. “There’s infrastructure, energy, and investment behind it.”
This reality means that while large organizations may experiment with custom AI models, many life sciences companies still rely on established technologies such as neural machine translation.
Regulation vs Innovation: A Moving Target
One of the most compelling discussions in the episode centers on the evolving relationship between AI and regulation.
Will regulators adapt to AI, or will AI need to conform?
Both Simon and Karen agree that regulators and AI must adapt to one another.
- Regulatory bodies like the FDA are արդեն integrating AI into workflows
- New laws (such as state-level AI legislation in the U.S.) are emerging
- Global governance frameworks are still taking shape
But one constant remains: human oversight is here to stay.
Multilingual Communication in a Global Industry
As CMO, Simon brings a unique lens to the conversation. He bridges technology, communication, and global reach.
Effective communication in life sciences isn’t just about translation. It’s about:
- Resonance across cultures
- Clarity across formats (text, audio, video)
- Compliance across jurisdictions
“Everything falls flat if the content does not create meaningful engagement,” Simon notes.
Here, the synergy of AI, localization, and human expertise is not just valuable, it’s essential.
Complexity Demands Expertise
This episode is a reminder that in life sciences, there are no shortcuts.
AI offers tremendous opportunity, but only when applied thoughtfully and responsibly. A partnership with domain experts who understand the stakes is crucial.
As Simon puts it, getting it wrong isn’t just costly, it can be dangerous.
And that’s what makes this conversation so important.
About Life Sciences – In Focus
Life Sciences – In Focus Podcast by Visatatec, a fascinating conversation with global life sciences experts. The show has multiple hosts and topics. Follow Life Sciences – In Focus on Spotify for all the latest episodes, or subscribe to the show on YouTube and Apple podcasts. Life Sciences – In Focus is available on many other podcast platforms. To learn more about the podcast, please visit https://vistatec.com/life-sciences-division.
About Vistatec
We have been helping some of the world’s most iconic brands to optimize their global commercial potential since 1997. Vistatec is one of the world’s leading global content solutions providers. HQ in Dublin, Ireland, with offices in Mountain View, California, USA. To learn more about Vistatec, please visit https://www.vistatec.com
